Literature DB >> 30343728

'Crystal' Clear? Lysophospholipid Receptor Structure Insights and Controversies.

Victoria A Blaho1, Jerold Chun2.   

Abstract

Lysophospholipids (LPLs), particularly sphingosine 1-phosphate (S1P) and lysophosphatidic acid (LPA), are bioactive lipid modulators of cellular homeostasis and pathology. The discovery and characterization of five S1P- and six LPA-specific G protein-coupled receptors (GPCRs), S1P1-5 and LPA1-6, have expanded their known involvement in all mammalian physiological systems. Resolution of the S1P1, LPA1, and LPA6 crystal structures has fueled the growing interest in these receptors and their ligands as targets for pharmacological manipulation. In this review, we have attempted to provide an integrated overview of the three crystallized LPL GPCRs with biochemical and physiological structure-function data. Finally, we provide a novel discussion of how chaperones for LPLs may be considered when extrapolating crystallographic and computational data toward understanding actual biological interactions and phenotypes.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  GPCR; apolipoprotein M; autotaxin; lysophosphatidic acid; sphingosine 1-phosphate

Mesh:

Substances:

Year:  2018        PMID: 30343728      PMCID: PMC6201317          DOI: 10.1016/j.tips.2018.08.006

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  81 in total

1.  Organization and Dynamics of Receptor Proteins in a Plasma Membrane.

Authors:  Heidi Koldsø; Mark S P Sansom
Journal:  J Am Chem Soc       Date:  2015-11-16       Impact factor: 15.419

Review 2.  GPCR Dynamics: Structures in Motion.

Authors:  Naomi R Latorraca; A J Venkatakrishnan; Ron O Dror
Journal:  Chem Rev       Date:  2016-09-13       Impact factor: 60.622

3.  Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors.

Authors:  K Bandoh; J Aoki; A Taira; M Tsujimoto; H Arai; K Inoue
Journal:  FEBS Lett       Date:  2000-07-28       Impact factor: 4.124

4.  Crystal Structure of Antagonist Bound Human Lysophosphatidic Acid Receptor 1.

Authors:  Jill E Chrencik; Christopher B Roth; Masahiko Terakado; Haruto Kurata; Rie Omi; Yasuyuki Kihara; Dora Warshaviak; Shinji Nakade; Guillermo Asmar-Rovira; Mauro Mileni; Hirotaka Mizuno; Mark T Griffith; Caroline Rodgers; Gye Won Han; Jeffrey Velasquez; Jerold Chun; Raymond C Stevens; Michael A Hanson
Journal:  Cell       Date:  2015-06-18       Impact factor: 41.582

5.  A role of Histidine151 in the lamprey gonadotropin-releasing hormone receptor-1 (lGnRHR-1): Functional insight of diverse amino acid residues in the position of Tyr of the DRY motif in GnRHR from an ancestral type II receptor.

Authors:  Takayoshi Kosugi; Stacia A Sower
Journal:  Gen Comp Endocrinol       Date:  2009-12-11       Impact factor: 2.822

Review 6.  Autotaxin: structure-function and signaling.

Authors:  Anastassis Perrakis; Wouter H Moolenaar
Journal:  J Lipid Res       Date:  2014-02-18       Impact factor: 5.922

Review 7.  The structure and function of G-protein-coupled receptors.

Authors:  Daniel M Rosenbaum; Søren G F Rasmussen; Brian K Kobilka
Journal:  Nature       Date:  2009-05-21       Impact factor: 49.962

8.  Serum lysophosphatidic acid is produced through diverse phospholipase pathways.

Authors:  Junken Aoki; Akitsu Taira; Yasukazu Takanezawa; Yasuhiro Kishi; Kotaro Hama; Tatsuya Kishimoto; Koji Mizuno; Keijiro Saku; Ryo Taguchi; Hiroyuki Arai
Journal:  J Biol Chem       Date:  2002-09-26       Impact factor: 5.157

9.  The pathway of ligand entry from the membrane bilayer to a lipid G protein-coupled receptor.

Authors:  Nathaniel Stanley; Leonardo Pardo; Gianni De Fabritiis
Journal:  Sci Rep       Date:  2016-03-04       Impact factor: 4.379

Review 10.  Coming of Age for Autotaxin and Lysophosphatidate Signaling: Clinical Applications for Preventing, Detecting and Targeting Tumor-Promoting Inflammation.

Authors:  Matthew G K Benesch; Iain T K MacIntyre; Todd P W McMullen; David N Brindley
Journal:  Cancers (Basel)       Date:  2018-03-15       Impact factor: 6.639

View more
  15 in total

Review 1.  Advancements in understanding the role of lysophospholipids and their receptors in lung disorders including bronchopulmonary dysplasia.

Authors:  Tara Sudhadevi; Alison W Ha; David L Ebenezer; Panfeng Fu; Vijay Putherickal; Viswanathan Natarajan; Anantha Harijith
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2020-03-10       Impact factor: 4.698

2.  Lysophospholipid G protein-coupled receptor binding parameters as determined by backscattering interferometry.

Authors:  Hirotaka Mizuno; Yasuyuki Kihara; Amanda Kussrow; Allison Chen; Manisha Ray; Richard Rivera; Darryl J Bornhop; Jerold Chun
Journal:  J Lipid Res       Date:  2018-11-21       Impact factor: 5.922

3.  Autoimmunity to Sphingosine-1-Phosphate-Receptors in Systemic Sclerosis and Pulmonary Arterial Hypertension.

Authors:  Hans Gluschke; Elise Siegert; Waldemar B Minich; Julian Hackler; Gabriela Riemekasten; Wolfgang M Kuebler; Szandor Simmons; Lutz Schomburg
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

4.  Glycerophosphodiesterase 3 (GDE3) is a lysophosphatidylinositol-specific ectophospholipase C acting as an endocannabinoid signaling switch.

Authors:  Fabienne Briand-Mésange; Véronique Pons; Sophie Allart; Julien Masquelier; Gaëtan Chicanne; Nicolas Beton; Bernard Payrastre; Giulio G Muccioli; Jérôme Ausseil; Jean-Luc Davignon; Jean-Pierre Salles; Hugues Chap
Journal:  J Biol Chem       Date:  2020-09-11       Impact factor: 5.157

Review 5.  Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities.

Authors:  Victoria A Blaho
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

6.  A Novel Function of the Lysophosphatidic Acid Receptor 3 (LPAR3) Gene in Zebrafish on Modulating Anxiety, Circadian Rhythm Locomotor Activity, and Short-Term Memory.

Authors:  Yu-Nung Lin; Gilbert Audira; Nemi Malhotra; Nguyen Thi Ngoc Anh; Petrus Siregar; Jen-Her Lu; Hsinyu Lee; Chung-Der Hsiao
Journal:  Int J Mol Sci       Date:  2020-04-18       Impact factor: 5.923

7.  Conditional Lpar1 gene targeting identifies cell types mediating neuropathic pain.

Authors:  Richard R Rivera; Mu-En Lin; Emily C Bornhop; Jerold Chun
Journal:  FASEB J       Date:  2020-06-17       Impact factor: 5.191

8.  Unlabeled lysophosphatidic acid receptor binding in free solution as determined by a compensated interferometric reader.

Authors:  Manisha Ray; Kazufumi Nagai; Yasuyuki Kihara; Amanda Kussrow; Michael N Kammer; Aaron Frantz; Darryl J Bornhop; Jerold Chun
Journal:  J Lipid Res       Date:  2020-06-08       Impact factor: 5.922

9.  Hypoxia Downregulates LPP3 and Promotes the Spatial Segregation of ATX and LPP1 During Cancer Cell Invasion.

Authors:  Kelly Harper; Karine Brochu-Gaudreau; Caroline Saucier; Claire M Dubois
Journal:  Cancers (Basel)       Date:  2019-09-19       Impact factor: 6.639

Review 10.  Targeting Lysophosphatidic Acid in Cancer: The Issues in Moving from Bench to Bedside.

Authors:  Yan Xu
Journal:  Cancers (Basel)       Date:  2019-10-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.